initial public offerings (IPOs) trading on American exchanges

Monday, November 3, 2014

Forward Pharma (FWP) began trading on the NASDAQ on 15 October 2014

Forward Pharma A/S, a biopharmaceutical company, focuses on the provision of dimethyl fumarate (DMF) formulations for the treatment of various immune disorders. It develops FP187, a DMF formulation to treat relapsing remitting multiple sclerosis and psoriasis. The company was founded in 2005 and is headquartered in Copenhagen, Denmark.

No comments:

Post a Comment